Philadelphia has rapidly emerged as a major hub for biotechnology, often referred to as “Cellicon Valley” due to its significant contributions to cell and gene therapy. This thriving ecosystem is driven by a combination of leading academic institutions, a robust network of research organizations, and a dynamic startup scene. Key institutions like the University of Pennsylvania and Children’s Hospital of Philadelphia have been instrumental in developing groundbreaking therapies, such as the first Food and Drug Administration (FDA)-approved gene therapy, Luxturna. Here are eight biotech companies based in Philadelphia to put on your radar, including uCity Square tenants.
- AUM LifeTech
- BlueWhale Bio
- Carisma Therapeutics (uCity Square)
- Century Therapeutics (uCity Square)
- Context Therapeutics
- iECURE
- Passage Bio
- Verismo Therapeutics (uCity Square)
Subscribe to our newsletter
"*" indicates required fields